ethyl 4-isothiocyanatobutanoate has been researched along with leupeptins in 1 studies
Studies (ethyl 4-isothiocyanatobutanoate) | Trials (ethyl 4-isothiocyanatobutanoate) | Recent Studies (post-2010) (ethyl 4-isothiocyanatobutanoate) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
---|---|---|---|---|---|
7 | 0 | 0 | 3,891 | 4 | 1,106 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartosova, Z; Bodo, J; Chalupa, I; Floch, L; Horakova, K; Jakubikova, J; Sedlak, J | 1 |
1 other study(ies) available for ethyl 4-isothiocyanatobutanoate and leupeptins
Article | Year |
---|---|
Apoptotic effect of ethyl-4-isothiocyanatobutanoate is associated with DNA damage, proteasomal activity and induction of p53 and p21cip1/waf1.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Butyrates; Caffeine; Cell Cycle; Cell Cycle Proteins; Cell Line; Chromosome Aberrations; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Flow Cytometry; Humans; Isothiocyanates; Leupeptins; Membrane Potential, Mitochondrial; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2006 |